Patents by Inventor Annabelle Freund-Renard

Annabelle Freund-Renard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7198791
    Abstract: The invention presents vaccine formulations comprising highly antigenic epitopes identified within the semi-conserved loop-I of domain III that are capable of eliciting parasite growth inhibitory antibodies. The cyclized or linear peptides can be applied by known adjuvants or be encapsulated by or attached onto the surface of liposomes or virosomes (IRIVs) which serve as human compatible antigen delivery systems. Both cyclized and linear versions of the peptide antigens are surprisingly effective in eliciting immune responses that are cross-reactive with parasite-expressed AMA-1.
    Type: Grant
    Filed: March 3, 2003
    Date of Patent: April 3, 2007
    Assignee: Pluschke, Gerd et al.
    Inventors: Gerd Pluschke, Mueller Markus, John Robinson, Rinaldo Zurbriggen, Annabelle Freund-Renard
  • Publication number: 20040175392
    Abstract: The invention presents vaccine formulations comprising highly antigenic epitopes identified within the semi-conserved loop-I of domain III that are capable of eliciting parasite growth inhibitory antibodies. The cyclized or linear peptides can be applied by known adjuvants or be encapsulated by or attached onto the surface of liposomes or virosomes (IRIVs) which serve as human compatible antigen delivery systems. Both cyclized and linear versions of the peptide antigens are surprisingly effective in eliciting immune responses that are cross-reactive with parasite-expressed AMA-1.
    Type: Application
    Filed: March 3, 2003
    Publication date: September 9, 2004
    Inventors: Gerd Pluschke, Markus S. Mueller, John A. Robinson, Rinaldo Zurbriggen, Annabelle Freund-Renard